- Tonix Pharmaceuticals Holding Corp to Host KOL Webinar TranscriptJan 31, 2024
- Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference TranscriptOct 19, 2023
- Tonix Pharmaceuticals Holding Corp At The June 1st Virtual Investor Summit TranscriptJun 01, 2023
- Tonix Pharmaceuticals Holding Corp At Investor Summit (Virtual) TranscriptMar 29, 2023
- Tonix Pharmaceuticals announces acquisition of Healion Bio antiviral portfolio TranscriptFeb 23, 2023
- Tonix Pharmaceuticals Holding Corpinterview with Dr. Seth Lederman, MD, and CEO TranscriptFeb 13, 2023
- Tonix Pharmaceuticals discusses exclusive license of potential monoclonal antibodies TranscriptFeb 01, 2023
- Tonix Pharmaceuticals Holding Corp at EBD Group Biotech Showcase TranscriptJan 10, 2023
- Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference TranscriptOct 26, 2022
- Tonix Pharmaceuticals Holding Corp at Q2 Investor Summit TranscriptMay 04, 2022
- Tonix Pharmaceuticals Holding Corp at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 27, 2022
- Tonix Pharmaceuticals Holding Corp at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 21, 2022
- Tonix Pharmaceuticals Holding Corp at Biotechnology Industry Organization (BIO) CEO & Investor Conference (Virtual) - Virtual Presentation TranscriptFeb 14, 2022
- Tonix Pharmaceuticals Holding Corp at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 23, 2021
- Tonix Pharmaceuticals Holding Corp at ICR Virtual Conference TranscriptJan 14, 2021
- Tonix Pharmaceuticals Holding Corp Business Update TranscriptDec 07, 2020
- Tonix Pharmaceuticals Holding Corp at SNN Network Virtual Conference TranscriptAug 06, 2020
- Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase TranscriptApr 29, 2020
- Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase TranscriptApr 22, 2020
- Tonix Pharmaceuticals Holding Corp at Tarsier Capital Management Spring Summit TranscriptMar 25, 2020
- Tonix Pharmaceuticals Holding Corp at Noble Financial Emerging Growth Investor Conference TranscriptFeb 18, 2020
Tonix Pharmaceuticals Holding Corp at Noble Capital Markets Investor Conference (Virtual) Transcript
Good morning. My name is Seth Lederman. I'm the CEO of Tonix Pharmaceuticals, and I'm grateful to you for coming to see the presentation. I'm grateful to the organizers for having us speak. Today, I've got a lot to say. I'm going to try to fit it into the time we have.
We have some exciting new analyses that have never been presented before about Long COVID, which is one of our programs. And I'm going to talk about the relationship of Long COVID to fibromyalgia, which is another condition which Tonix has a program in.
But first, let me take a breath and say Tonix is a public company. We're traded on NASDAQ under the ticker TNXP, and I will be making forward-looking statements, and I refer you to our SEC documents for more complete information about the company.
One of the most distinctive things about Tonix is the broad portfolio of products that we have in development. So we have an engine of discovery, manufacturing, regulatory, clinical development, and other things. And that's why it's been efficient
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)